Feng Shi
ORCID: 0009-0008-0494-6772Also affiliated with Shanghai Tunnel Engineering (China), United Imaging Healthcare (China), State Key Laboratory of Clean Energy Utilization, Zhejiang University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial”.
Xiangqian Zheng, Yuan Zhang, Feng Shi, Ying Cheng, Zhuming Guo +14 more
Postnatal age-related change of brain volume and its association with neurobehavior outcome in term neonates
Linlin Zhu, Peng xuan Bai, Yao Ge, Congcong Liu, Na Zhang +6 more
Sheng‐Che Hung, Dinggang Shen, Li Wang, Meng‐Hsiang Chen, Shuai Wang +3 more